ASTRIA THERAPEUTICS INC's ticker is and the CUSIP is 04635X102. A total of 69 filers reported holding ASTRIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,462,035 | +139.1% | 598,128 | +166.9% | 1.43% | +105.6% |
| Q2 2023 | $1,866,536 | -49.0% | 224,074 | -18.5% | 0.69% | -37.7% |
| Q1 2023 | $3,657,646 | -62.3% | 275,011 | -57.8% | 1.11% | -71.6% |
| Q4 2022 | $9,698,000 | +69.9% | 651,330 | +3.1% | 3.92% | +150.3% |
| Q3 2022 | $5,709,000 | – | 631,579 | – | 1.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 1,347,088 | $17,916,270 | 9.94% |
| Fairmount Funds Management LLC | 1,901,397 | $25,288,580 | 4.35% |
| Ikarian Capital, LLC | 869,390 | $11,562,887 | 2.62% |
| Affinity Asset Advisors, LLC | 529,369 | $7,040,608 | 2.32% |
| Logos Global Management LP | 1,044,960 | $13,897,968 | 1.99% |
| Ghost Tree Capital, LLC | 450,000 | $5,985,000 | 1.77% |
| Vivo Capital, LLC | 1,681,199 | $22,359,947 | 1.55% |
| Opaleye Management Inc. | 302,000 | $4,096,400 | 1.23% |
| Tri Locum Partners LP | 275,011 | $3,657,646 | 1.11% |
| Saturn V Capital Management LP | 101,339 | $1,347,809 | 1.01% |